Suppression of renal CN1 activity and the subsequent great increase in renal carnosine and anserine concentrations represents a promising therapeutic approach to mitigate or prevent chronic kidney diseases such as diabetic nephropathy. This evidence concerns the gene CNDP1 and diabetic kidney disease.